Track MEDNAX, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

MEDNAX, Inc. MD · Stock Open MEDNAX, Inc. in new tab

31.30 USD
P/E
17.14
EPS
1.83
P/B
2.81
ROE
17.25
Beta
0.61
Target Price
30.08 USD
Loading chart...
Key Metrics
Earnings dateFeb. 18, 2027
P/E17.14
EPS1.83
Book Value11.16
Price to Book2.81
Debt/Equity72.03
% Insiders2.115%
Growth
Revenue Growth0.02%
Earnings Growth-0.30%
Estimates
Forward P/E12.51
Forward EPS2.51
Target Mean Price30.08

DCF valuation

Model fair value for MEDNAX, Inc. (MD)
Result
Sign in to run the valuation for MD.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
6 analysts · consensus Hold · mean target 30.08 USD (low 28.00, high 33.50) · as of 12 Nov 2026
Low 28.00
Mean 30.08
High 33.50
Price 31.30
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

MEDNAX, Inc. Logo MEDNAX, Inc. Analysis (MD)

United States Health Care Official Website Stock

Is MEDNAX, Inc. a good investment? MEDNAX, Inc. (MD) is currently trading at 31.30 USD. Market analysts have a consensus price target of 30.08 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 17.14. This valuation is generally in line with the broader market.

Earnings Schedule: MEDNAX, Inc. is expected to release its next earnings report on Feb. 18, 2027. The market consensus estimate for Forward EPS is 2.51.

Investor FAQ

Does MEDNAX, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is MEDNAX, Inc.?

MEDNAX, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 18, 2027. The company currently has a trailing EPS of 1.83.

Company Profile

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Exchange Ticker
FRA (Germany) PDC.F
NYQ (United States) MD
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
April 28, 2006 2:1
Dec. 20, 2013 2:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion